pertuzumab: Clinical Trials

7 trials of pertuzumab, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 recruiting, 2 completed, 1 not yet recruiting, 1 unknown. 7 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 47Recruiting 3, Completed 2, Not yet recruiting 1, Unknown 1

Follow pertuzumab: new trials by email Literature Review of pertuzumab trials Research Report on pertuzumab

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Olaparib+Trastuzumab+Pertuzumab Neoadjuvant for Elderly HER2+ Breast Cancer
olaparib combined with trastuzumab and pertuzumab - Elderly Females, HER2 + Breast Cancer
Phase 4RecruitingWen-Ming Cao452026-05-252026-07-10
Efficacy and Safety of Lobaplatin and Carboplatin as Neoadjuvant Therapy in HER-2 Positive Breast Cancer
lobaplatin, carboplatin, Docetaxel or albumin paclitaxel - Breast Cancer
Phase 4Not yet recruitingShandong Cancer Hospital and Institute4682025-08-012025-07-30
A Study for the Adjuvant Treatment of Breast Cancer
Docetaxel, Carboplatin, Trastuzumab - Breast Cancer
Phase 4RecruitingSecond Affiliated Hospital, Zhejiang University, School of Medicine24132022-07-102022-07-01
A Study for the Neoadjuvant Treatment of Breast Cancer
Docetaxel, Carboplatin, Trastuzumab - Breast Cancer
Phase 4RecruitingSecond Affiliated Hospital, Zhejiang University, School of Medicine15762022-07-102022-07-01
Neoadjuvant Ontruzant (SB3) in Patients With HER2-positive Early Breast Cancer: An Open-Label (NeoON)
Ontruzant, Chemotherapy, Pertuzumab - Breast Cancer, Breast Neoplasms
Phase 4UnknownInstitut fuer Frauengesundheit1082021-07-112023-04-18
Safety Study of Pertuzumab (in Combination With Trastuzumab and Docetaxel) in Indian Participants With Breast Cancer
Docetaxel, Pertuzumab, Trastuzumab - Breast Cancer
Phase 4CompletedHoffmann-La Roche522015-08-172019-10-29
MINT I Multi- Institutional Neo-adjuvant Therapy MammaPrint Project I
TAC chemotherapy, TC chemotherapy, Dose Dense AC or FEC100 followed by paclitaxel or docetaxel chemotherapy - Breast Cancer
Phase 4CompletedAgendia2262011-10-012018-06-28

Conditions studied

Breast Neoplasms (7)

Sponsors

Second Affiliated Hospital, Zhejiang University, School of Medicine (2)  ·  Agendia (1)  ·  Hoffmann-La Roche (1)  ·  Institut fuer Frauengesundheit (1)  ·  Shandong Cancer Hospital and Institute (1)  ·  Wen-Ming Cao (1)

Countries

China (4)  ·  Germany (1)  ·  India (1)  ·  United States (1)

Top investigators

Andreas Schneeweiss, MD, Prof. (1)  ·  Anil Kukreja, MD (1)  ·  Charles E Cox, MD (1)